The use of carbohydrate antigen (CA) 15-3 as a tumor marker in detecting breast cancer

Pakistan Journal of Biological Sciences

Volumn 11, Issue 15, 2008, Pages 1945-1948

  Agyei Frempong, Margaret T ^a   Darko, E ^a   Addai, Beatrice Wiafe ^b  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b Peace and Love Hospital   (Ghana)

Author keywords

Benign breast disease; Biopsy specimen; Breast malignancy; Non invasive detection; Pre clinical state

Indexed keywords

MUCIN 1; TUMOR MARKER;

ARTICLE; BLOOD; BREAST TUMOR; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MUCIN-1; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 57649210355     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2008.1945.1948     Document Type: Article

References (8)

1. Cheli, C.D., D.L. Morris, J. Goldblatt, I. Neaman and W.J. Allard, 1998. Multicenter evaluation of the Bayer Immuno I CA 15-3 assay. Clin. Chem., 44: 765-772.
2. Duffy, M.J., 1999. CA 15-3 and related mucins as circulating markers in breast cancer. Ann. Clin. Biochem., 36: 579-586.
3. Elzagheid, A., T. Kuopio, S. Pyrhonen and Y. Collan, 2006. Lymph node status as a guide to selection of available prognostic markers in breast cancer: The clinical practice of the future? Diagnostic Pathol., 1: 41-41.
4. Keyhani, M., S. Nasizadeh and A. Dehghannejad, 2005. Serum CA 15-3 Measurement in Breast Cancer patients before and after mastectomy. Arch. Iranian Med., 8: 263-266.
5. Lumachi, F., A.A. Brandes, M. Ermani, G. Bruno and P. Boccagni, 2000. Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors. Anticancer Res., 20: 4751-4755.
6. Mohammad Nejad, J., M.J. Rasaee, B. Saqhafi, M. Rajabibazl, F. Rahbarizadeh, K. Omidfar and M. Paknejad, 2006. A new competitive enzyme linked immunosorbent assay (MRP83-CA 15-3) for MUC 1 measurement in breast cancer. J. Immunoassay Immunochem., 27: 139-149.
7. Tondini, C., D.F. Hayes and D.W. Kufe, 1989. Circulating tumor markers in breast cancer. Hematol Oncol. Clin. North Am., 3: 653-674.
8. Vizcarra, E., A. Lluch, R. Cibrian, F. Jarque, V. Alberola and V. Belloch et al., 1996. Value of CA 15-3 m breast cancer and comparison with CEA and TPA: A study of specificity in disease-free follow-up patients and sensitivity in patients at diagnosis of first metastasis. Breast Cancer Res. Treat., 37: 209-216.